Page 950 - Basic _ Clinical Pharmacology ( PDFDrive )

936 SECTION VIII Chemotherapeutic Drugs

PREP AR A TIONS German PI, Aweeka FT: Clinical pharmacology of artemisinin-based combination
therapies. Clin Pharmacokinet 2008;47:91.
A V AIL ABLE Hill DR et al: Primaquine: Report from CDC expert meeting on malaria chemo-
prophylaxis I. Am J Trop Med Hyg 2006;75:402.
GENERIC NAME AVAILABLE AS John GK et al: Primaquine radical cure of Plasmodium vivax: A critical review of
the literature. Malar J 2012;11:280.
Artemether/lumefantrine Coartem, Riamet McGready R et al: Adverse effects of falciparum and vivax malaria and the safety of
Artesunate * antimalarial treatment in early pregnancy: A population-based study. Lancet
Artesunate-pyronaridine Pyramax Infect Dis 2012;12:388.
Atovaquone Generic, Mepron Morris CA et al: Review of the clinical pharmacokinetics of artesunate and its
active metabolite dihydroartemisinin following intravenous, intramuscular,
Atovaquone-proguanil Malarone oral or rectal administration. Malar J 2011;10:263.
Benznidazole * Nadjm B, Behrens RH: Malaria: An update for physicians. Infect Dis Clin North
Chloroquine Generic, Aralen Am 2012;26:243.
Clindamycin Generic, Cleocin Nosten F et al: Antimalarial drugs in pregnancy: A review. Curr Drug Saf 2006;1:1.
Doxycycline Generic, Vibramycin Rehman K, et al: Haemolysis associated with the treatment of malaria with arte-
misinin derivatives: a systematic review of current evidence. Int J Infect Dis
Eflornithine Vaniqa, Ornidyl 2014;29:268.
Iodoquinol Diquinol, Yodoxin Rosenthal PJ: Artesunate for the treatment of severe falciparum malaria. N Engl J
Mefloquine Generic, Lariam Med 2008;358:1829.
Melarsoprol * Mel B Rosenthal PJ: The interplay between drug resistance and fitness in malaria para-
sites. Mol Microbiol 2013;89:1025.
Metronidazole Generic, Flagyl Stepniewska K, White NJ: Pharmacokinetic determinants of the window of
Nifurtimox * selection for antimalarial drug resistance. Antimicrob Agents Chemother
Nitazoxanide Alinia 2008;52:1589.
Paromomycin Generic, Humatin Taylor WR, White NJ: Antimalarial drug toxicity: A review. Drug Saf 2004;
Pentamidine Pentam 300, Pentacarinat, pentami- 27:25.
dine isethionate, Nebupent (aerosol) Tilley L et al: Artemisinin Action and Resistance in Plasmodium falciparum. Trends
Parasitol 2016 32:682.
Primaquine Generic White NJ: Cardiotoxicity of antimalarial drugs. Lancet Infect Dis 2007;7:549.
Pyrimethamine Daraprim White NJ et al: Malaria. Lancet 2014;383:723.
Quinidine gluconate Generic Whitty CJ, Chiodini PL, Lalloo DG: Investigation and treatment of imported
Quinine Generic malaria in non-endemic countries. BMJ 2013;346:f2900.
Sodium stibogluconate * World Health Organization: Guidelines for the treatment of malaria. Geneva.
Sulfadoxine-pyrimethamine Fansidar 2015. www.who.int/malaria/publications/atoz/9789241549127/en/.
Suramin *
Tinidazole Generic, Tindamax Intestinal Protozoal Infections
Fox LM, Saravolatz LD: Nitazoxanide: A new thiazolide antiparasitic agent. Clin
* Available in the USA only from the Drug Service, CDC, Atlanta, Georgia (phone: Infect Dis 2005;40:1173.
404-639-3670; www.cdc.gov/laboratory/drugservice/).
Granados CE et al: Drugs for treating giardiasis. Cochrane Database Syst Rev
2012;(12):CD007787.
REFERENCES Leitsch D: Drug resistance in the microaerophilic parasite Giardia lamblia. Curr
Trop Med Rep 2015;2:128.
General Marcos LA, Gotuzzo E: Intestinal protozoan infections in the immunocompro-
mised host. Curr Opin Infect Dis 2013;26:295.
Kappagoda S, Singh U, Blackburn BG: Antiparasitic therapy. Mayo Clin Proc Pierce KK et al: Update on human infections caused by intestinal protozoa. Curr
2011;86:561. Opin Gastroenterol 2009;25:12.
Medical Letter: Drugs for parasitic infections. Med Lett Drugs Ther Pritt BS, Clark DG: Amebiasis. Mayo Clin Proc 2008;83:1154.
2013;Supplement.
Ross AG et al: Enteropathogens and chronic illness in returning travelers. N Engl
J Med 2013;368:1817.
Malaria Rossignol JF: Cryptosporidium and Giardia: Treatment options and prospects for
Ashley EA et al: Tracking Resistance to Artemisinin Collaboration (TRAC). Spread new drugs. Exp Parasitol 2010;124:45.
of artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med Wright SG: Protozoan infections of the gastrointestinal tract. Infect Dis Clin
2014;371:411. North Am 2012;26:323.
Baird KJ, Maguire JD, Price RN: Diagnosis and treatment of Plasmodium vivax
malaria. Adv Parasitol 2012;80:203. Trypanosomiasis & Leishmaniasis
Boggild AK et al: Atovaquone-proguanil: Report from the CDC expert meeting on
malaria chemoprophylaxis (II). Am J Trop Med Hyg 2007;76:208. Aronson NE et al: A randomized controlled trial of local heat therapy versus intra-
Bukirwa H et al: Artesunate plus pyronaridine for treating uncomplicated Plasmo- venous sodium stibogluconate for the treatment of cutaneous Leishmania
dium falciparum malaria. Cochrane Database Syst Rev 2014;(3):CD006404. major infection. PLoS Negl Trop Dis 2010;4:e628.
Dondorp AM et al: Artesunate versus quinine in the treatment of severe falciparum Ben Salah A et al: Topical paromomycin with or without gentamicin for cutaneous
malaria in African children (AQUAMAT): An open-label, randomised trial. leishmaniasis. N Engl J Med 2013;368:524.
Lancet 2010;376:1647. Bern C: Chagas’ disease. N Engl J Med 2015;373:456.
Efferth T, Kaina B: Toxicity of the antimalarial artemisinin and its derivatives. Crit Bhattacharya SK et al: Phase 4 trial of miltefosine for the treatment of Indian
Rev Toxicol 2010;40:405. visceral leishmaniasis. J Infect Dis 2007;196:591.